Development of an adverse outcome pathway for acetylcholinesterase inhibition leading to acute mortality.
about
A Workflow to Investigate Exposure and Pharmacokinetic Influences on High-Throughput in Vitro Chemical Screening Based on Adverse Outcome PathwaysMechanistic modeling of insecticide risks to breeding birds in North American agroecosystems.Adverse outcome pathway (AOP) development I: strategies and principlesAdverse outcome pathway development II: best practices.The Role of Omics in the Application of Adverse Outcome Pathways for Chemical Risk Assessment.Limitations of toxicity characterization in life cycle assessment: Can adverse outcome pathways provide a new foundation?Weight of evidence evaluation of a network of adverse outcome pathways linking activation of the nicotinic acetylcholine receptor in honey bees to colony death.Drug Metabolism in Preclinical Drug Development: A Survey of the Discovery Process, Toxicology, and Computational Tools.Editor's Highlight: Sequence Alignment to Predict Across Species Susceptibility (SeqAPASS): A Web-Based Tool for Addressing the Challenges of Cross-Species Extrapolation of Chemical Toxicity.Evaluation of the scientific underpinnings for identifying estrogenic chemicals in nonmammalian taxa using mammalian test systems.Planarian cholinesterase: in vitro characterization of an evolutionarily ancient enzyme to study organophosphorus pesticide toxicity and reactivation.Planarian cholinesterase: molecular and functional characterization of an evolutionarily ancient enzyme to study organophosphorus pesticide toxicity.Editorial: Special Issue "Effect-related evaluation of anthropogenic trace substances-concepts for genotoxicity, neurotoxicity and endocrine effects".In search of a comprehensible set of endpoints for the routine monitoring of neurotoxicity in vertebrates: sensory perception and nerve transmission in zebrafish (Danio rerio) embryos.AOP-DB: A database resource for the exploration of Adverse Outcome Pathways through integrated association networks.A mechanism-based 3D-QSAR approach for classification and prediction of acetylcholinesterase inhibitory potency of organophosphate and carbamate analogs.Early phosphoproteomic changes for adverse outcome pathway development in the fathead minnow (Pimephales promelas) brain.In Response: Quantitative adverse outcome pathways for prediction of adverse effects-An academic perspective
P2860
Q30044590-80C73C5F-A8D3-45CD-A125-31B22423AF55Q33632855-A5E8E0C8-E4D3-4F79-BCB1-243325E83E4BQ35055206-6192698A-1B46-4016-B03E-0B5D40F17C9CQ35055209-6B91B03A-7A82-44CA-A016-3D96B1BEBBB0Q36376553-4AAE4F36-7339-4BE9-BE97-876FF7AE446CQ38578965-9F2D5310-B404-4BB2-AACC-0FBE8621482EQ39105285-85A825CB-65BF-4486-9F4D-EC28BE175E16Q39182452-E1A0FF94-6328-444F-8D18-12C8F2D456A8Q39637745-96107810-079D-45F5-87CE-3321B0192831Q39854165-9A2868CD-EB00-4D30-A5EC-19952E5FD11AQ43969490-7FEF3BA0-8E61-4B5C-AA1E-DC950EACEF8AQ46350813-DD464092-F655-4FA1-AF30-922B0E56C0A4Q47721784-49544069-992C-4EA0-9B78-5C9A67CF020EQ48206268-10DF58E8-C637-4244-BE1F-6817354F747BQ49904301-38AAFAE2-84D0-4CA5-8C81-6D939A12D18CQ51297155-5A0D0718-E172-4B85-BF55-FE45CE14EB52Q55687881-9E88A015-4838-4D1E-B3A4-8C3F3638C534Q57003829-CDA49124-45FA-456D-A24F-526C3A41B35F
P2860
Development of an adverse outcome pathway for acetylcholinesterase inhibition leading to acute mortality.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh
2014年學術文章
@zh-hant
name
Development of an adverse outc ...... on leading to acute mortality.
@en
type
label
Development of an adverse outc ...... on leading to acute mortality.
@en
prefLabel
Development of an adverse outc ...... on leading to acute mortality.
@en
P2093
P2860
P356
P1476
Development of an adverse outc ...... on leading to acute mortality.
@en
P2093
Carlie A LaLone
Christine L Russom
Daniel L Villeneuve
Gerald T Ankley
P2860
P304
P356
10.1002/ETC.2662
P577
2014-08-25T00:00:00Z